Cabozantinib plus atezolizumab for non-clear cell kidney cancer
In this video interview, Dr Monty Pal from the City [...]
Lenvatinib plus everolimus for non clear cell kidney cancer
Treating non-clear cell renal cell carcinoma (RCC) is challenging because [...]
Differences in survival with tremelimumab due to different types of kidney cancer
Most people have a type of kidney cancer called clear [...]
Cabozantinib plus atezolizumab for non-clear cell renal cell carcinoma
In this video interview with Dr Monty Pal from the [...]
ESMO Virtual 2020: Cabozantinib plus atezolizumab in non-clear cell kidney cancer
Non-clear cell renal cell carcinoma (RCC) accounts for about 25% [...]
Safety and efficacy of nivolumab for non-clear cell kidney cancer
Nivolumab alone and in combination with ipilimumab is used for the treatment of [...]
Summary from ASCO 2020 virtual meeting
This article nicely summarises the most exciting research highlights from [...]
Cabozantinib in combination with immunotherapy for advanced kidney cancer
In this video interview, Dr Monty Pal from the City [...]
Diagnostic biomarkers for rare subtype of kidney cancer
There are more than 10 different subtypes of renal cell [...]
Atezolizumab and bevacizumab for non-clear cell renal cell carcinoma
In this video interview from Practice Update, Dr Brad McGregor [...]
